From: Muscle loss phenotype in COPD is associated with adverse outcomes in the UK Biobank
No MLP criteria (N = 25,981) | MLP criteria (N = 29,801) | Standardized difference (%) | ||||
---|---|---|---|---|---|---|
Factor | N | Statistics | N | Statistics | p-value | |
Sex | 25,981 | 29,801 | 24.72 | < 0.001c | ||
Female | 13,163 (50.7) | 11,464 (38.5) | ||||
Male | 12,818 (49.3) | 18,337 (61.5) | ||||
Age at recruitment (years) | 25,981 | 57.6 ± 7.8 | 29,801 | 60.5 ± 6.9 | 38.71 | < 0.001a2 |
Ethnicity | 25,981 | 29,801 | 0 | < 0.001c | ||
British | 24,446 (94.1) | 28,057 (94.1) | ||||
Irish | 653 (2.5) | 899 (3.0) | ||||
Any other white background | 882 (3.4) | 845 (2.8) | ||||
Body mass index (BMI) (Kg/m2) | 25,981 | 28.2 ± 4.4 | 29,743 | 25.3 ± 4.2 | -67.3 | < 0.001a2 |
FEV1, percent predicted | 25,981 | 79.7 ± 17.8 | 29,801 | 78.7 ± 19.1 | -5.5 | < 0.001a2 |
FEV1, GOLD stage | 25,981 | 29,801 | 8.43 | < 0.001c | ||
> 80% (mild) | 13,298 (51.2) | 14,842 (49.8) | ||||
50–79% (moderate) | 11,242 (43.3) | 12,653 (42.5) | ||||
30–49% (severe) | 1,266 (4.9) | 1,978 (6.6) | ||||
< 30% (very severe) | 175 (0.67) | 328 (1.1) | ||||
FEV1, liters | 25,981 | 2.4 ± 0.74 | 29,801 | 2.4 ± 0.79 | -4 | < 0.001a2 |
FEV1/FVC ratio | 25,981 | 0.65 ± 0.06 | 29,801 | 0.64 ± 0.07 | -14.8 | < 0.001a2 |
Alcohol drinker status | 25,961 | 29,758 | 5.45 | < 0.001c | ||
Never | 699 (2.7) | 981 (3.3) | < 0.001d | |||
Previous | 892 (3.4) | 1,292 (4.3) | < 0.001d | |||
Current | 24,370 (93.9) | 27,485 (92.4) | < 0.001d | |||
Smoking status | 25,871 | 29,656 | 7.66 | < 0.001c | ||
Never | 10,686 (41.3) | 11,981 (40.4) | 0.0264d | |||
Previous | 10,732 (41.5) | 11,460 (38.6) | < 0.001d | |||
Current | 4,453 (17.2) | 6,215 (21.0) | < 0.001d | |||
Pack years of smoking (years) | 11,418 | 25.5 [14.0, 39.4] | 13,407 | 27.5 [14.8, 42.0] | 8.06 | < 0.001b |
Ever addicted to any substance or behavior | 7,782 | 622 (8.0) | 8,203 | 612 (7.5) | -2 | 0.21c |
History of cancer diagnosis | 25,891 | 2,001 (7.7) | 29,698 | 2,754 (9.3) | 5.54 | < 0.001c |
Doctor diagnosed emphysema | 6,010 | 56 (0.93) | 6,425 | 101 (1.6) | 5.76 | 0.001c |
Age emphysema diagnosed by doctor | 56 | 54.4 ± 13.1 | 101 | 58.7 ± 11.1 | 35.23 | 0.032a1 |
IPAQ activity group | 21,263 | 23,966 | 8.39 | < 0.001c | ||
Low | 3,698 (17.4) | 4,539 (18.9) | ||||
Moderate | 8,379 (39.4) | 9,745 (40.7) | ||||
High | 9,186 (43.2) | 9,682 (40.4) | ||||
Summed minutes activity (minutes) | 21,263 | 105.0 [60.0, 180.0] | 23,966 | 100.0 [50.0, 180.0] | -6.5 | < 0.001b |
MET minutes per week for walking (minutes/week) | 21,263 | 693.0 [330.0, 1386.0] | 23,966 | 693.0 [330.0, 1386.0] | -1.5 | 0.12b |